Liposome-encapsulated vincristine, vinblastine and vinorelbine: A comparative study of drug loading and retention

被引:163
作者
Zhigaltsev, IV
Maurer, N
Akhong, QF
Leone, R
Leng, E
Wang, J
Semple, SC
Cullis, PR
机构
[1] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada
[2] Inex Pharmaceut Corp, Burnaby, BC V5J 5J8, Canada
基金
加拿大健康研究院;
关键词
liposomes; vincristine; vinorelbine; vinblastine; drug release;
D O I
10.1016/j.jconrel.2005.01.010
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A comparative study of the loading and retention properties of three structurally very closely related vinca alkaloids (vincristine, vinorelbine and vinblastine) in liposomal formulations has been performed. All three vinca alkaloids showed high levels of encapsulation when accumulated into egg sphingomyelin/cholesterol vesicles in response to a transmembrane pH gradient generated by the use of the ionophore A23187 and encapsulated MgSO4. However, despite the close similarities of their structures the different vinca drugs exhibited very different release behavior, with vinblastine and vinorelbine being released faster than vincristine both in vitro and in vivo. The differences in loading and retention can be related to the lipophilicity of the drugs tested, where the more hydrophobic drugs are released more rapidly. It was also found that increasing the drug-to-lipid ratio significantly enhanced the retention of vinca alkaloids when the ionophore-based method was used for drug loading. In contrast, drug retention was not dependent on the initial drug-to-lipid ratio for vinca drugs loaded into liposomes containing an acidic citrate buffer. The differences in retention can be explained on the basis of differences in the physical state of the drug inside the liposomes. The drug-to-lipid ratio dependence of retention observed for liposomes loaded with the ionophore technique may provide a way to improve the retention characteristics of liposomal formulations of vinca drugs. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 27 条
[1]   An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes [J].
Abraham, SA ;
Edwards, K ;
Karlsson, G ;
Hudon, N ;
Mayer, LD ;
Bally, MB .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (03) :449-461
[2]  
Boman NL, 1995, J LIPOS RES, V5, P523, DOI 10.3109/08982109509010240
[3]   Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes [J].
Boman, NL ;
Tron, VA ;
Bally, MB ;
Cullis, PR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (04) :351-355
[4]  
Boman NL, 1998, LONG CIRCULATING LIP, P29
[5]   Loading of doxorubicin into liposomes by forming Mn2+-drug complexes [J].
Cheung, BCL ;
Sun, THT ;
Leenhouts, JM ;
Cullis, PR .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1414 (1-2) :205-216
[6]   Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles [J].
Cullis, PR ;
Hope, MJ ;
Bally, MB ;
Madden, TD ;
Mayer, LD ;
Fenske, DB .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1997, 1331 (02) :187-211
[7]   Ionophore-mediated uptake of ciprofloxacin and vincristine into large unilamellar vesicles exhibiting transmembrane ion gradients [J].
Fenske, DB ;
Wong, KF ;
Maurer, E ;
Maurer, N ;
Leenhouts, JM ;
Boman, N ;
Amankwa, L ;
Cullis, PR .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1414 (1-2) :188-204
[8]  
Fiske CH, 1925, J BIOL CHEM, V66, P375
[9]   Phase I study of liposomal vincristine [J].
Gelmon, KA ;
Tolcher, A ;
Diab, AR ;
Bally, MB ;
Embree, L ;
Hudon, N ;
Dedhar, C ;
Ayers, D ;
Eisen, A ;
Melosky, B ;
Burge, C ;
Logan, P ;
Mayer, LD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :697-705
[10]   ACCUMULATION OF DOXORUBICIN AND OTHER LIPOPHILIC AMINES INTO LARGE UNILAMELLAR VESICLES IN RESPONSE TO TRANSMEMBRANE PH GRADIENTS [J].
HARRIGAN, PR ;
WONG, KF ;
REDELMEIER, TE ;
WHEELER, JJ ;
CULLIS, PR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1149 (02) :329-338